欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0639/001
药品名称Linezolid Krka 2 mg/ml Infusionslösung
活性成分
    • linezolid 2.0 mg/ml
剂型Solution for infusion
上市许可持有人Krka, d.d., Novo mesto Šmarješka cesta 6 8501 Novo mesto Slovenia
参考成员国 - 产品名称Austria (AT)
Linezolid Krka 2 mg/ml - Infusionslösung
互认成员国 - 产品名称
    • Germany (DE)
      Linezolid TAD 2 mg/ml Infusionslösung
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Italy (IT)
    • Poland (PL)
      Linezolid Krka
    • Latvia (LV)
      Linezolid Krka 2 mg/ml šķīdums infūzijām
    • Lithuania (LT)
      Linezolid Krka 2 mg/ml infuzinis tirpalas
    • Estonia (EE)
      LINEZOLID KRKA
    • Hungary (HU)
      LINEZOLID KRKA 2 mg/ml oldatos infúzió
    • Bulgaria (BG)
    • Czechia (CZ)
      Linezolid Krka 2 mg/ml
    • Romania (RO)
    • Slovakia (SK)
      Linezolid Krka 2 mg/ml infúzny roztok
    • Slovenia (SI)
      Linezolid Krka 2 mg/ml raztopina za infundiranje
    • Croatia (HR)
      Linezolid Krka 2 mg/ml otopina za infuziju
许可日期2016/10/25
最近更新日期2023/06/05
药物ATC编码
    • J01XX08 linezolid
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase